(Q46957533)

26 December 2017

title

Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children (English)

1 reference

26 December 2017

author

Jorge Vicente

3

1 reference

26 December 2017

author name string

Blanca Sinués

1

1 reference

26 December 2017

Ana Fanlo

2

1 reference

26 December 2017

Esteban Mayayo-Sinués

4

1 reference

26 December 2017

Esteban Mayayo

5

1 reference

26 December 2017

Jose I Labarta

6

1 reference

26 December 2017

Angel Ferrandez-Longás

7

1 reference

26 December 2017

publication date

9 October 2007

1 reference

26 December 2017

Basic and Clinical Pharmacology and Toxicology

published in

1 reference

26 December 2017

volume

102

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

45-49

1 reference

26 December 2017

CYP2A6: a human coumarin 7-hydroxylase

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone-deficient children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Effect of allopurinol on caffeine disposition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Expression of CYP2A genes in human liver and extrahepatic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Nicotine metabolism and CYP2A6 allele frequencies in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2007.00139.X

10.1111/J.1742-7843.2007.00139.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017